Share on StockTwits

Acadia Healthcare Company (NASDAQ:ACHC) major shareholder Norman King Carter III sold 30,000 shares of the stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $41.73, for a total transaction of $1,251,900.00. Following the transaction, the insider now directly owns 10,896 shares of the company’s stock, valued at approximately $454,690. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Shares of Acadia Healthcare Company (NASDAQ:ACHC) traded up 1.00% on Tuesday, hitting $42.29. 924,495 shares of the company’s stock traded hands. Acadia Healthcare Company has a one year low of $30.70 and a one year high of $53.87. The stock has a 50-day moving average of $44.17 and a 200-day moving average of $46.24. The company has a market cap of $2.138 billion and a price-to-earnings ratio of 49.49.

Acadia Healthcare Company (NASDAQ:ACHC) last announced its earnings results on Tuesday, April 29th. The company reported $0.28 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.28. The company had revenue of $206.10 million for the quarter, compared to the consensus estimate of $194.83 million. The company’s quarterly revenue was up 24.4% on a year-over-year basis. Analysts expect that Acadia Healthcare Company will post $1.31 EPS for the current fiscal year.

ACHC has been the subject of a number of recent research reports. Analysts at Ned Davis Research upgraded shares of Acadia Healthcare Company from a “sell” rating to a “neutral” rating in a research note on Monday, April 21st. Separately, analysts at Cantor Fitzgerald raised their price target on shares of Acadia Healthcare Company from $52.00 to $57.00 in a research note on Tuesday, March 4th. Finally, analysts at BMO Capital Markets reiterated a “positive” rating on shares of Acadia Healthcare Company in a research note on Friday, February 21st. Five investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Acadia Healthcare Company presently has a consensus rating of “Buy” and a consensus target price of $48.79.

Acadia Healthcare Company, Inc is a provider of inpatient behavioral healthcare services in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.